Home Cart 0 Sign in  

[ CAS No. 2766-43-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 2766-43-0
Chemical Structure| 2766-43-0
Structure of 2766-43-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2766-43-0 ]

Related Doc. of [ 2766-43-0 ]

Alternatived Products of [ 2766-43-0 ]

Product Details of [ 2766-43-0 ]

CAS No. :2766-43-0 MDL No. :MFCD00191869
Formula : C9H17NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :SANNKFASHWONFD-LURJTMIESA-N
M.W : 219.24 Pubchem ID :7019177
Synonyms :
Boc-Ser-OMe
Chemical Name :Boc-Ser-OMe

Calculated chemistry of [ 2766-43-0 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.78
Num. rotatable bonds : 7
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 52.34
TPSA : 84.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.5 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.28
Log Po/w (XLOGP3) : 0.2
Log Po/w (WLOGP) : 0.04
Log Po/w (MLOGP) : 0.01
Log Po/w (SILICOS-IT) : -0.14
Consensus Log Po/w : 0.48

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.86
Solubility : 30.0 mg/ml ; 0.137 mol/l
Class : Very soluble
Log S (Ali) : -1.54
Solubility : 6.31 mg/ml ; 0.0288 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.79
Solubility : 35.2 mg/ml ; 0.161 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.92

Safety of [ 2766-43-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2766-43-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2766-43-0 ]
  • Downstream synthetic route of [ 2766-43-0 ]

[ 2766-43-0 ] Synthesis Path-Upstream   1~46

  • 1
  • [ 2766-43-0 ]
  • [ 45121-22-0 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 51, p. 9389 - 9392
  • 2
  • [ 24424-99-5 ]
  • [ 5680-80-8 ]
  • [ 2766-43-0 ]
YieldReaction ConditionsOperation in experiment
94% With triethylamine In dichloromethane at 0 - 20℃; The crude (5)-methyl 2-amino-3-hydroxypropanoate hydrochloride (0.29 mol) was suspended in DCM (200 mL) and to this mixture was added triethylamine (79 mL, 0.57 mol) and Boc20 (68 g, 0.31 mol) at 0 °C. The cooling bath was removed and the reaction mixture was stirred at ambient temperature overnight and then diluted with MTBE (300 mL). The mixture was filtered and the filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography on silica gel to afford (5)-methyl 2- ((tert-butoxycarbonyl)amino)-3-hydroxypropanoate (60 g, 94percent yield) as a colorless oil.
86% With triethylamine In tetrahydrofuran at 20℃; to a solution of L-serine methyl ester hydrochloride (10.00 g, 64.5 mmol) and Boc20 (28.12 g, 129 mmol) in THF (258 ml_) was slowly added Et3N (27 ml_, 194 mmol) at room temperature. The reaction was stirred overnight, then quenched with saturated NaHC03 and brine, concentrated under vacuum and diluted with CH2CI2 and brine. The mixtures were separated and the aqueous layers were extracted with CH2CI2 three times, the combined organic phases were washed with brine, dried andiconcentrated, the residue was purified by silica gel column chromatography which gave the title compound as colourless oil (14.147 g, 86 percent yield).
82% With triethylamine In tetrahydrofuran at 25℃; for 5 h; Automated synthesizer To a solution of methyl L-serinate hydrochloride (1, 2.00 g, 12.9 mmol, 1.00equiv., RF1) in THF (50.0 mL, RR2) were added Et3N (5.36 mL, 38.7 mmol,3.00 equiv, RR3) and Boc2O (3.38 g, 15.5 mmol, 1.20 equiv, RR1) in THF (11.0mL, RR1) diluted with THF (5.00 mL, RR4) and transferred to RF1 at 25 °C.After being stirred at the same temperature for 5 h, the reaction mixture (RF1)was quenched with 1 M HCl aq. (RS2) and the aqueous layer was extractedwith two portions of ethyl acetate (RS1). The combined organic layer waswashed with 10percent NaCl aq. (RS3), dried over Na2SO4 (DT1), filtered, andconcentrated in vacuo. The residue was purified by column chromatography on silica gel (50percent ethyl acetate in hexane) to give methyl (tert-butoxycarbonyl)-Lserinate (2.31 g, 10.5 mmol, 82percent) as a colorless oil.
51.1% With sodium hydroxide; triethylamine In dichloromethane; water (1)
Synthesis of N-t-butoxycarbonyl-D,L-serine methyl ester (65)
Triethylamine[1.78 ml(12.5 mmol.)] was added, under stirring at room temperatre, to a solution of DL-serine methyl ester hydrochloride[3.89 g(12.5 mmol.)] in methylene chloride(50 ml), and the mixture was stirred for 30 minutes, and there was added di-t-butyl dicarbonate[6.00 g(13.8 mmol.)].
The whole mixture was stirred for 20 hours at room temperature.
The reaction mixture was washed with 1N aqueous solution of sodium hydroxide and water, successively, and dried, and then the solvent was distilled off.
The residue was subjected to column chromatography using silica gel, and eluted with hexane-ethyl acetate(2:1), to obtain the desired product (65)[2.80 g(51.1percent)] as a colorless oily substance.
IR(Neat)cm-1: 3370(br), 1740(br), 1700(br).
NMR(90 MHz,CDCl3) δ: 1.45(9H,s), 3.77(3H,s), 3.90(2H,m), 4.35(1H,m), 5.50(1H,br.d,J=7 Hz).
51.1% With sodium hydroxide; triethylamine In dichloromethane; water 1)
Synthesis of N-t-butoxycarbonyl-D,L-serine methyl ester (65)
Triethylamine [1.78 m (12.5 mmol.)] was added, under stirring at room temperature, to a solution of DL-serine methyl ester hydrochloride [3.89 g (12.5 mmol.)] in methylene chloride (50 m), and the mixture was stirred for 30 minutes, to which was added di-t-butyl dicarbonate [6.00 g (13.8 mmol.)].
The whole mixture was stirred for 20 hours at room temperature.
The reaction mixture was washed with 1N aqueous solution of sodium hydroxide and water, successively, and dried, and then the solvent was distilled off.
The residue was subjected to column chromatography using silica gel, and eluted with hexane-ethyl acetate (2: 1), to obtain the desired product (65) [2.80 g (51.1percent)] as a colorless oily substance.
9.4 g With triethylamine In acetonitrile at 0 - 20℃; for 6 h; To a solution of L-serine (5 g,47.6 mmol) in ice-cold methanol (142 mL) was dropwise added acetyl chloride (5 mL, 71.4mmol). Then the reaction mixture was warmed to room temperature and stirred overnight. Solventwas evaporated to afford a white solid, which was used without further purification.The L-serine methyl ester hydrochloride salt (7.4 g, 47.6 mmol) and triethylamine (20.0 mL, 142.8mmol) was added to a solution of Boc-anhydride (11.0 g, 47.6 mmol) in acetonitrile (160 mL) at 0. The reaction mixture was warmed to room temperature and stirred for 6 h. DCM (200 mL)was added and washed with HCl (1 N, 3 x 80 mL) and brine (100 mL). The organic layer wasdried over anhydrous Na2SO4 and concentrated. The residue was purified by flash chromatography(ethyl acetate / petroleum ether = 1:1) to afford 5 as a thick oil (9.4 g, 90percent). [α]D20 = +7.79 (c =0.42, CHCl3) [lit.1 [α]D26 = +9.7 (c = 4.29, CHCl3)]. 1H NMR (400 MHz, CDCl3): δ 5.80 (d, J = 6.8Hz, 1H), 4.35 (br s, 1H), 3.97 (m, 1H), 3.86 (m, 1H), 3.77 (s, 3H), 1.45 (s, 9H). 13C NMR (100MHz, CDCl3): δ 171.2, 155.4, 76.5, 62.4, 55.3, 52.0, 27.8. HRMS (ESI): calcd. for C9H17NO5Na[M+Na]+ 242.0999; found 242.1004.

Reference: [1] European Journal of Organic Chemistry, 2000, # 1, p. 115 - 124
[2] Organic Letters, 2003, vol. 5, # 24, p. 4599 - 4602
[3] Journal of Organic Chemistry, 2015, vol. 80, # 1, p. 40 - 51
[4] Journal of the American Chemical Society, 2016, vol. 138, # 43, p. 14218 - 14221
[5] Organic and Biomolecular Chemistry, 2013, vol. 11, # 19, p. 3089 - 3093
[6] Journal of Organic Chemistry, 1994, vol. 59, # 14, p. 3890 - 3897
[7] Patent: WO2014/152127, 2014, A1, . Location in patent: Paragraph 00319; 00321
[8] Angewandte Chemie - International Edition, 2014, vol. 53, # 31, p. 8190 - 8194[9] Angew. Chem., 2014, vol. 126, # 31, p. 8329 - 8333,5
[10] Russian Journal of General Chemistry, 2010, vol. 80, # 12, p. 2519 - 2520
[11] Journal of Medicinal Chemistry, 2018,
[12] Synthesis, 1994, # 1, p. 31 - 33
[13] Journal of Medicinal Chemistry, 2015, vol. 58, # 10, p. 4204 - 4219
[14] European Journal of Organic Chemistry, 2015, vol. 2015, # 24, p. 5414 - 5423
[15] Patent: WO2007/68474, 2007, A1, . Location in patent: Page/Page column 42; 43
[16] Journal of the American Chemical Society, 2011, vol. 133, # 4, p. 1044 - 1051
[17] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 24, p. 3697 - 3703
[18] Organic Letters, 2011, vol. 13, # 10, p. 2614 - 2617
[19] Beilstein Journal of Organic Chemistry, 2017, vol. 13, p. 106 - 110
[20] Journal of Organic Chemistry, 2008, vol. 73, # 5, p. 1661 - 1681
[21] Phosphorus, Sulfur and Silicon and Related Elements, 2000, vol. 164, p. 277 - 291
[22] Journal of the American Chemical Society, 2017, vol. 139, # 35, p. 12228 - 12239
[23] Patent: US4987130, 1991, A,
[24] Patent: EP278621, 1991, B1,
[25] Helvetica chimica acta, 1990, vol. 73, p. 1373 - 1390
[26] Synthetic Communications, 1992, vol. 22, # 7, p. 979 - 985
[27] Tetrahedron, 1998, vol. 54, # 22, p. 6051 - 6064
[28] Tetrahedron Letters, 1998, vol. 39, # 51, p. 9389 - 9392
[29] Synthetic Communications, 1999, vol. 29, # 14, p. 2377 - 2391
[30] Synlett, 2003, # 3, p. 349 - 352
[31] Journal of Medicinal Chemistry, 2006, vol. 49, # 11, p. 3064 - 3067
[32] Organic and Biomolecular Chemistry, 2007, vol. 5, # 23, p. 3826 - 3833
[33] Patent: US2005/101674, 2005, A1, . Location in patent: Page/Page column 5; sheet 6
[34] Organic Letters, 2010, vol. 12, # 1, p. 4 - 7
[35] Dalton Transactions, 2012, vol. 41, # 17, p. 5225 - 5234
[36] Journal of Medicinal Chemistry, 2012, vol. 55, # 23, p. 10460 - 10474
[37] Organic and Biomolecular Chemistry, 2013, vol. 11, # 18, p. 2943 - 2946
[38] Tetrahedron Letters, 2013, vol. 54, # 48, p. 6511 - 6513
[39] Patent: US2014/275590, 2014, A1, . Location in patent: Paragraph 0309
[40] Patent: WO2014/140787, 2014, A2, . Location in patent: Paragraph 00256
[41] Organic Letters, 2016, vol. 18, # 8, p. 1812 - 1815
[42] European Journal of Organic Chemistry, 2017, vol. 2017, # 6, p. 1045 - 1051
[43] Organic Syntheses, 2000, vol. 77, p. 64 - 64
[44] Angewandte Chemie - International Edition, 2018, vol. 57, # 18, p. 5147 - 5150[45] Angew. Chem., 2018, vol. 130, p. 5241 - 5244,4
[46] Organic Letters, 2018, vol. 20, # 12, p. 3574 - 3578
[47] Organic Letters, 2018,
  • 3
  • [ 3262-72-4 ]
  • [ 74-88-4 ]
  • [ 2766-43-0 ]
YieldReaction ConditionsOperation in experiment
93% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 4.5 h; Cooling with ice To a solution of 4 (1.26 g, 6.1 mmol) and potassiumcarbonate (0.91 g, 6.6 mmol) in DMF (12 mL) cooled on an ice bath was added a solution of iodomethane (0.80mL, 12.8 mmol) in DMF (6 mL). After stirring for 30 min on an ice bath, the mixture was stirred for 4 h at rt.Precipitates were filtered off, and the filtrate was added with water and extracted with EtOAc. The organiclayer was washed with water and brine, dried over MgSO4, and evaporated. The obtained colorless oil waspurified by silica gel column chromatography (hexane:EtOAc = 1:1) to give 5 as a colorless oil (1.24 g, 93percent).The spectral data of 5 were identical to the literature,25 and the purity was confirmed by 1H NMR.
87.4%
Stage #1: With potassium carbonate In N,N-dimethyl-formamide for 0.25 h; Cooling with ice
Stage #2: for 24 h;
Under ice cooling, 18.7 g of N-Boc-L-serine was dissolved in 200 ml of DMF and 13.25 g of solid K2CO3 was added and for 15 minutes, and then 41.6 g (3.2 eq) of Mel was added, followed by stirring for 24 hours.
After the reaction, the reaction solution was filtered through celite and concentrated.
The residue was extracted by liquid separation using 400 ml of water and 150 ml x 4 of ethyl acetate and dried over sodium sulfate.
The ethyl acetate layer was concentrated and subjected to silica gel column chromatography to obtain 17.1 g (87.4percent) of an N-Boc-L-serine methyl ester as a transparent oily product.
5.3 g With potassium carbonate In N,N-dimethyl-formamide at 0 - 20℃; for 1.5 h; To an ice-cold solution of L-serine (3.2 g, 30 mmol) in 1 M sodium hydroxide (60 mL) was added di-tert-butyl dicarbonate [(Boc)2O] (7.8 g, 36 mmol) in dioxane (25 mL). The mixture was stirred at 5 °C for 30 min, then allowed to warm to room temperature over 3.5 h. The reaction mixture was concentrated to half its original volume, quenched with 1 M potassium bisulfate (60 mL) and extracted with ethyl acetate (3 x 30 mL). The combined extracts were washed with brine (2 x 30 mL) and water (30 mL), dried over Na2SO4 and concentrated in vacuo. The crude product (5.8 g) was used to the next step. To an ice-cold solution of N-Boc-L-serine (5.8 g, 28 mmol) in DMF (40 mL) solid potassium carbonate (4.3 g, 31 mmol) was added. After stirring for 10 min methyl iodide (3.5 mL, 56 mmol) was added and the reaction mixture was stirred at 0 °C for 30 min. The reaction was allowed to reach room temperature and stirred for an additional hour. Then the reaction mixture was filtered to remove inorganic material, water (20 mL) was added and the filtrate was extracted with diethyl ether (3 x 20 mL). The combined extracts were washed with brine (2 x 20 mL) and water (10 mL), dried over Na2SO4. After concentration in vacuo 5.3 g (86percent yield) of N-Boc-L-serine methyl ester was obtained as a colorless oil. The product was sufficiently pure to be used in the next step without further purification. 1H and 13C NMR spectra were consistent with literature data.2 IR (ATR, cm-1) ν: 3433, 2978, 1743, 1710, 1368, 1163; 1H NMR (400 MHz, CDCl3) δ: 5.67 (br s, 1H, NH), 4.25 (br s, 1H, CH-N), 3.85-3.74 (m, 2H, CH2-O), 3.63 (s, 3H, OCH3), 1.35 (s, 9H, Boc); 13C NMR (400 MHz, CDCl3) δ: 171.4, 155.7, 79.9, 62.7, 55.5, 52.3, 28.0; MS (ESI) m/z: [M+Na]+ 242.
Reference: [1] Organic Letters, 2003, vol. 5, # 23, p. 4253 - 4256
[2] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
[3] Patent: EP2319850, 2011, A1, . Location in patent: Page/Page column 8
[4] Tetrahedron Letters, 2003, vol. 44, # 28, p. 5251 - 5253
[5] Journal of the American Chemical Society, 2006, vol. 128, # 51, p. 16684 - 16691
[6] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4427 - 4431
[7] Organic and Biomolecular Chemistry, 2005, vol. 3, # 13, p. 2476 - 2481
[8] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 2, p. 179 - 182
[9] European Journal of Organic Chemistry, 1998, # 6, p. 945 - 959
[10] Tetrahedron Letters, 2001, vol. 42, # 34, p. 5953 - 5954
[11] Tetrahedron Letters, 2007, vol. 48, # 16, p. 2857 - 2859
[12] Chemistry - A European Journal, 2009, vol. 15, # 17, p. 4428 - 4436
[13] Nature Chemistry, 2010, vol. 2, # 4, p. 280 - 285
[14] Synthesis, 2010, # 18, p. 3063 - 3066
[15] Medicinal Chemistry, 2014, vol. 10, # 6, p. 609 - 618
[16] Patent: US2015/51183, 2015, A1, . Location in patent: Paragraph 0460
[17] Organic Syntheses, 1992, vol. 70, p. 18 - 18
[18] Tetrahedron, 2018, vol. 74, # 38, p. 5392 - 5398
[19] Journal of Organometallic Chemistry, 2018, vol. 876, p. 1 - 9
  • 4
  • [ 5680-80-8 ]
  • [ 2766-43-0 ]
YieldReaction ConditionsOperation in experiment
81% With triethylamine In dichloromethane at 38 - 40℃; General procedure: L-Phenylalanine methyl ester hydrochloride (5.0 g, 23.2 mmol), triethyl amine (2.47 g, 24.4 mmol) and 2 (7.24 g, 24.4 mmol) were added to dichloromethane (50 mL) and stirred at reflux temp (38-40°C) for 5h. After completion of the reaction, filtered to remove salts and the filtrate was washed with 5percent KHSO4 (20 mL), water (25 mL), brine (25 mL), and dried over sodium sulfate. The solvent was evaporated under reduced pressure to obtain a pale yellow oil. The oil was purified by column chromatography (silica gel, ethyl acetate/ hexane, 8:2) to afford 5.96 g (92percent) Methyl (tert-butoxycarbonyl)-L-phenylalaninate as a colorless oil.
Reference: [1] Synthetic Communications, 2017, vol. 47, # 22, p. 2127 - 2132
  • 5
  • [ 2788-84-3 ]
  • [ 24424-99-5 ]
  • [ 2766-43-0 ]
Reference: [1] Synthesis, 2010, # 16, p. 2816 - 2822
[2] Tetrahedron Letters, 1995, vol. 36, # 1, p. 67 - 70
[3] New Journal of Chemistry, 2018, vol. 42, # 4, p. 2450 - 2458
[4] Tetrahedron, 1985, vol. 41, # 10, p. 1833 - 1845
[5] Tetrahedron Letters, 2008, vol. 49, # 16, p. 2527 - 2532
[6] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 17, p. 4621 - 4628
[7] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 6, p. 997 - 1000
[8] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 2, p. 663 - 677
[9] Patent: US5969135, 1999, A,
[10] Patent: WO2005/41899, 2005, A2, . Location in patent: Page/Page column 130-131
[11] Journal of Medicinal Chemistry, 2008, vol. 51, # 24, p. 8012 - 8018
[12] Synthesis, 2010, # 3, p. 443 - 446
[13] Journal of Organic Chemistry, 2011, vol. 76, # 15, p. 6075 - 6087
[14] Monatshefte fur Chemie, 2014, vol. 145, # 3, p. 509 - 515
[15] Letters in Organic Chemistry, 2013, vol. 10, # 9, p. 626 - 631
[16] Journal of Organic Chemistry, 2018, vol. 83, # 7, p. 3738 - 3745
[17] Patent: WO2005/41899, 2005, A2, . Location in patent: Page/Page column 130-131
  • 6
  • [ 24424-99-5 ]
  • [ 5680-80-8 ]
  • [ 2766-43-0 ]
YieldReaction ConditionsOperation in experiment
86% With potassium hydroxide; triethylamine In tetrahydrofuran; methanol; ethyl acetate SYNTHESIS EXAMPLE 1
(Synthesis of Boc-1-serine methylester 2) (The term "Boc" as used herein means a t-butoxycarbonyl group.)
6.6 g (0.1 mol) of potassium hydroxide (purity, 85percent) was dissolved in 150 ml of methanol.
To this was added 15.6 g (0.1 mol) of 1-serine methylester hydrochloride and the mixture was stirred for 45 minutes.
The resulting solution was mixed with 10.1 g (0.1 mol) of triethylamine and then with 21.8 g (0.1 mol) di-tert-butyl-dicarbonate which has been dissolved in 100 ml of tetrahydrofuran (THF) solution.
After standing overnight, the THF in the mixture was distilled off under reduced pressure.
A portion of ethyl acetate was added to the reside remaining after the distillation and the organic layer was washed with water.
After drying with sodium sulfate, the solvent was distilled off.
The resulting residue was then subjected to silica gel chromatography (hexane/ethyl acetate=7/3) to obtain 18.9 g (0.086 mol) of the Boc-1-series methylester 2 as a purified colorless liquid with the yield of 86percent.
Reference: [1] Patent: US5198224, 1993, A,
  • 7
  • [ 24424-99-5 ]
  • [ 88099-67-6 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 10, p. 2057 - 2059
  • 8
  • [ 186581-53-3 ]
  • [ 3262-72-4 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 25, p. 3037 - 3040
[2] Tetrahedron, 1982, vol. 38, p. 697
[3] Russian Journal of Bioorganic Chemistry, 2008, vol. 34, # 6, p. 660 - 667
[4] Tetrahedron Letters, 1989, vol. 30, # 29, p. 3799 - 3802
[5] Tetrahedron Letters, 1984, vol. 25, # 51, p. 5855 - 5858
[6] Journal of Organic Chemistry, 1987, vol. 52, # 12, p. 2361 - 2364
[7] Journal of the Chemical Society, Chemical Communications, 1995, # 10, p. 1061 - 1062
[8] Organic Letters, 2001, vol. 3, # 9, p. 1331 - 1334
[9] Patent: US2004/14816, 2004, A1, . Location in patent: Page/Page column 15
[10] Organic Syntheses, 1992, vol. 70, p. 18 - 18
  • 9
  • [ 850848-18-9 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 2005, vol. 46, # 13, p. 2299 - 2301
[2] Tetrahedron, 2007, vol. 63, # 45, p. 10921 - 10929
  • 10
  • [ 80963-10-6 ]
  • [ 2766-43-0 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 17, p. 6599 - 6601
  • 11
  • [ 24424-99-5 ]
  • [ 2104-89-4 ]
  • [ 2766-43-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 4, p. 759 - 769
  • 12
  • [ 24424-99-5 ]
  • [ 2766-43-0 ]
YieldReaction ConditionsOperation in experiment
7.16 g With triethylamine In tetrahydrofuran at 0 - 20℃; for 12 h; To a solution of (L)-serinemethyl ester HC1 (5.00 g, 32.1 mmol) in dry tetrahydrofuran (THF)(64.3 mL) was added triethylamine (TEA)(9.85 mL, 70.7 mmol) followed by a solution of (Boc)20 (7.46 mL, 32.1 mmol) in THF (30 mL) at 0 °C. The reaction mixture was stirred for 12 hours at room temperature. After concentration of the resulting mixture in vacuo, the residue was partitioned betweenethyl acetate (EtOAc) and water. The aqueous layer was extracted with EtOAc twice. The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo to obtain the title compound (7.16 g, >99percent) as colorless oil, which was used for the next reaction withOut further purification.
Reference: [1] Patent: WO2015/156601, 2015, A1, . Location in patent: Page/Page column 23; 24
  • 13
  • [ 1450734-58-3 ]
  • [ 2766-43-0 ]
YieldReaction ConditionsOperation in experiment
10% With t-butyl bromide In acetonitrile for 0.5 h; Reflux General procedure: To asolution of the PMB ether (1 mmol) in acetonitrile (10 mL), t-BuBr (1.1 equiv)was added and stirred at reflux. After completion of the reaction (monitored byTLC), it was concentrated under reduced pressure and the resulting crude wasdissolved in ethyl acetate (50 mL) and washed with saturated sodiumhydrogenocarbonate (25 mL). The aqueous layer was extracted with ethylacetate (2 5 mL) and the combine organic layer was washed with brinesolution, dried (MgSO4), concentrated under reduced pressure and the residuewas purified by column chromatography (silica gel, EtOAc, cyclohexane) toafford the corresponding alcohol.
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 49, p. 6823 - 6826
  • 14
  • [ 5680-80-8 ]
  • [ 404586-94-3 ]
  • [ 2766-43-0 ]
Reference: [1] Organic Letters, 2002, vol. 4, # 4, p. 585 - 587
[2] Tetrahedron, 2006, vol. 62, # 50, p. 11599 - 11607
  • 15
  • [ 3262-72-4 ]
  • [ 2766-43-0 ]
Reference: [1] Patent: US5451691, 1995, A,
  • 16
  • [ 1187581-93-6 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 36, p. 5094 - 5097
  • 17
  • [ 126645-26-9 ]
  • [ 2766-43-0 ]
Reference: [1] Journal of Organic Chemistry, 2000, vol. 65, # 17, p. 5077 - 5088
  • 18
  • [ 24424-99-5 ]
  • [ 2766-43-0 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 23, p. 4253 - 4256
[2] Tetrahedron Letters, 2003, vol. 44, # 28, p. 5251 - 5253
[3] Journal of Organic Chemistry, 1987, vol. 52, # 12, p. 2361 - 2364
[4] Patent: EP2319850, 2011, A1,
[5] Medicinal Chemistry, 2014, vol. 10, # 6, p. 609 - 618
[6] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
[7] Organic Syntheses, 1992, vol. 70, p. 18 - 18
[8] Organic Syntheses, 1992, vol. 70, p. 18 - 18
[9] Synthetic Communications, 2017, vol. 47, # 22, p. 2127 - 2132
[10] Tetrahedron, 2018, vol. 74, # 38, p. 5392 - 5398
  • 19
  • [ 3262-72-4 ]
  • [ 584-08-7 ]
  • [ 2766-43-0 ]
Reference: [1] Patent: US5380945, 1995, A,
  • 20
  • [ 67-56-1 ]
  • [ 56-45-1 ]
  • [ 24424-99-5 ]
  • [ 2766-43-0 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 1, p. 19 - 22
[2] Tetrahedron, 1996, vol. 52, # 36, p. 11673 - 11694
[3] Journal of Organic Chemistry, 2003, vol. 68, # 1, p. 50 - 54
  • 21
  • [ 5680-80-8 ]
  • [ 108655-53-4 ]
  • [ 2766-43-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1986, vol. 23, p. 1459 - 1463
  • 22
  • [ 78545-07-0 ]
  • [ 2766-43-0 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 17, p. 6599 - 6601
  • 23
  • [ 288-32-4 ]
  • [ 33403-97-3 ]
  • [ 18162-48-6 ]
  • [ 2766-43-0 ]
Reference: [1] Patent: US5580872, 1996, A,
  • 24
  • [ 1026816-02-3 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 45, p. 10921 - 10929
  • 25
  • [ 67-56-1 ]
  • [ 3262-72-4 ]
  • [ 2766-43-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 1999, vol. 7, # 12, p. 2985 - 2990
[2] Synthetic Communications, 1993, vol. 23, # 2, p. 153 - 156
  • 26
  • [ 58632-95-4 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 1988, vol. 29, # 25, p. 3037 - 3040
[2] Tetrahedron Letters, 1989, vol. 30, # 29, p. 3799 - 3802
  • 27
  • [ 2788-84-3 ]
  • [ 34619-03-9 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 48, p. 6069 - 6072
  • 28
  • [ 1205122-02-6 ]
  • [ 76-05-1 ]
  • [ 954143-62-5 ]
  • [ 2766-43-0 ]
Reference: [1] Synthesis, 2009, # 21, p. 3633 - 3641
  • 29
  • [ 34619-03-9 ]
  • [ 2766-43-0 ]
Reference: [1] Tetrahedron Letters, 1984, vol. 25, # 51, p. 5855 - 5858
  • 30
  • [ 56-45-1 ]
  • [ 24424-99-5 ]
  • [ 2766-43-0 ]
Reference: [1] Journal of Organometallic Chemistry, 2003, vol. 674, # 1-2, p. 24 - 31
  • 31
  • [ 186581-53-3 ]
  • [ 56-45-1 ]
  • [ 24424-99-5 ]
  • [ 2766-43-0 ]
Reference: [1] Journal of Organic Chemistry, 1996, vol. 61, # 16, p. 5418 - 5424
  • 32
  • [ 54555-84-9 ]
  • [ 3262-72-4 ]
  • [ 74-88-4 ]
  • [ 2766-43-0 ]
  • [ 134167-07-0 ]
  • [ 134167-08-1 ]
  • [ 134167-06-9 ]
Reference: [1] Tetrahedron Letters, 1991, vol. 32, # 10, p. 1283 - 1286
  • 33
  • [ 54555-84-9 ]
  • [ 3262-72-4 ]
  • [ 74-88-4 ]
  • [ 935-04-6 ]
  • [ 2766-43-0 ]
  • [ 134167-07-0 ]
  • [ 134167-08-1 ]
  • [ 134167-06-9 ]
Reference: [1] Tetrahedron Letters, 1991, vol. 32, # 10, p. 1283 - 1286
  • 34
  • [ 2766-43-0 ]
  • [ 53308-95-5 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 48, p. 6069 - 6072
  • 35
  • [ 2766-43-0 ]
  • [ 6404-28-0 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 48, p. 6069 - 6072
  • 36
  • [ 2766-43-0 ]
  • [ 98541-64-1 ]
Reference: [1] Journal of Organometallic Chemistry, 2018, vol. 876, p. 1 - 9
  • 37
  • [ 2766-43-0 ]
  • [ 98-59-9 ]
  • [ 56926-94-4 ]
YieldReaction ConditionsOperation in experiment
91% at 0℃; for 8 h; Inert atmosphere To a solution of 5 (0.67 g, 3.1 mmol)in pyridine (10 mL) cooled on an ice bath was added p‐toluenesulfonyl chloride (3.0 g, 15.7 mmol). Afterstirring for 8 h on an ice bath under nitrogen atmosphere, Et2O (10 mL) was added to the solution, and themixture was further stirred at rt for 14 h. The resulting yellow solution was washed with water, 10percent potassium hydrogen sulfate, saturated sodium bicarbonate, and brine. The ethereal layer was dried over MgSO4 andevaporated. The obtained colorless oil was purified by silica gel column chromatography (hexane:EtOAc = 2:1)to give 6 as a white solid (1.05 g, 91percent). The spectral data of 6 were identical to the literature.32 The purity wasconfirmed by 1H NMR.
85% With pyridine In dichloromethane at 0 - 20℃; for 16 h; To a solution of N-t-butoxycarbonyl-L-serine methyl ester (6.57 g, 30 mmol) in CH2Cl2 (30 mL) at 0° C. was added pyridine (10 mL).
Then, p-toluenesulfonyl chloride (6.84 g, 36 mmol) was added portionwise.
The mixture was allowed to warm to rt and was stirred for 16 h.
The mixture was then poured into EtOAc/H2O (150 mL/100 mL).
The organic layer was washed with H2O (100 mL), brine (100 mL), dried (Na2SO4), and filtered.
After removal of solvent, the mixture was purified by silica gel chromatography using EtOAc/hexane (1/9 to 7/13) as the eluent to give 9.5 g of the desired compound (85percent) as a white solid. 1H NMR (300 MHz, CDCl3) δ 7.76 (d, J=6.0 Hz, 2H), 7.35 (d, J=9.0 Hz, 2H), 5.34 (d, J=6.0 Hz, 1H), 4.52-4.49 (m, 1H), 4.39 (dd, J=12.0, 3.0 Hz, 1H), 4.29 (dd, J=9.0, 3.0 Hz, 1H), 3.69 (s, 3H), 2.45 (s, 3H), 1.42 (s, 9H).
Reference: [1] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
[2] Tetrahedron Letters, 1987, vol. 28, # 48, p. 6069 - 6072
[3] Journal of the American Chemical Society, 2006, vol. 128, # 51, p. 16684 - 16691
[4] Patent: US2008/103129, 2008, A1, . Location in patent: Page/Page column 57
[5] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 1, p. 405 - 408
[6] Chemical Communications, 2014, vol. 50, # 41, p. 5487 - 5489
[7] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 16, p. 2443 - 2447
[8] Organic Syntheses, 2005, vol. 81, p. 77 - 88
[9] Tetrahedron, 1985, vol. 41, # 10, p. 1833 - 1845
[10] Synlett, 2016, vol. 27, # 19, p. 2685 - 2688
[11] Journal of Organic Chemistry, 1990, vol. 55, # 13, p. 3998 - 4006
[12] Tetrahedron Letters, 1994, vol. 35, # 4, p. 551 - 554
[13] Phosphorus, Sulfur and Silicon and the Related Elements, 1998, vol. 136, p. 611 - 616
[14] Tetrahedron Letters, 2003, vol. 44, # 28, p. 5251 - 5253
[15] Organic and Biomolecular Chemistry, 2005, vol. 3, # 13, p. 2476 - 2481
[16] Organic Letters, 2001, vol. 3, # 9, p. 1331 - 1334
[17] Patent: US4795815, 1989, A,
[18] Journal of the American Chemical Society, 2017, vol. 139, # 35, p. 12228 - 12239
  • 38
  • [ 2766-43-0 ]
  • [ 93267-04-0 ]
YieldReaction ConditionsOperation in experiment
68% at 0 - 20℃; for 1.5 h; A mixture of triphenylphosphine (131 g, 0.500 mol) and imidazole (34 g, 0.50 mol) in DCM (600 mL) was cooled to 0 °C and iodide (127 g, 0.50 mol) was added in small portions over 0.5 h. The cooling bath was removed and the mixture was stirred for 0.5 h. After the mixture was re-cooled to 0 °C, a solution of (5)-methyl 2-((tert- butoxycarbonyl)amino)-3-hydroxypropanoate (73 g, 0.33 mol) in DCM (300 mL) was added dropwise. After the addition, the cooling bath was removed and the mixture was allowed to warm to ambient temperature and stirred for 1.5 h. The mixture was filtered and the filtrate was concentrated to remove most of the solvent. MTBE (400 mL) was added to the residue and the mixture was filtered to remove triphenylphosphine oxide. The filtrate was concentrated and the residue was purified by flash column chromatography on silica gel to afford (i?)-methyl 2-((tert-butoxycarbonyl)amino)-3-iodopropanoate (74.0 g, 68percent yield) as a colorless solid.
67%
Stage #1: With methyltriphenoxyphosphonium iodide In N,N-dimethyl-formamide at 0℃; for 0.5 h;
Stage #2: With sodium hydrogencarbonate In water; N,N-dimethyl-formamide for 0.25 h;
Triphenylphosphite methiodide (Fieser and Fieser, Reagents for Organic Synthesis, Vol. 4, p557; 34Og, 753 mmol, 1.4 equiv.) was added in one portion to a solution of (S)-2- rert-butyloxycarbonylamino-3-hydroxypropionic acid methyl ester (118g, 538 mmol) in dry N,N-dimethylformamide (1.1 L) at 0°C. After 30 minutes at O0C solid sodium bicarbonate (27Og) was added followed by water (1. IL). The resulting mixture was stirred vigorously for 15 minutes and then extracted with 1:1 diethylether/hexanes (3 x 80OmL). The combined organic extracts were washed with 0.5M sodium hydroxide (5 x IL) and brine (2 x IL), dried over magnesium sulfate, filtered, and the filtrate concentrated under reduced pressure. The resulting orange oil was loaded onto a SiO2 plug (2" x 7") and eluted with 5percent EtOAc/hexanes to afford (R)-methyl 2-(tert-butoxycarbonylamino)-3-iodopropanoate as a pinkish oil, which solidified (118.5g, 67percent) 1H NMR (CDC13; 400MHz): δppm 5.32 (m, IH), 4.51 (m, IH), 3.81 (s, 3H), 3.58 (m, 2H), 1.45 (s, 9H).
65% With 1H-imidazole; iodine; triphenylphosphine In dichloromethane at 0 - 20℃; for 3 h; Inert atmosphere Triphenylphosphine (66.0 g, 0.250 mol) and imidazole (17.1 g, 0.250 mol) were dissolved in methylene chloride (900 ml). After cooling to 0° C., iodine (64.0 g, 0.250 mol) was added thereto, and the temperature was gradually raised from 0° C. to room temperature in the presence of nitrogen gas, followed by stirring for 10 minutes. After cooling to 0° C., a methylene chloride solution (100 of methyl N-(tert-butoxycarbonyl)-L-serinate (45.0 g, 0.200 mol) was slowly added dropwise over one hour, followed by stirring at room temperature for 2 hours. After the reaction solution was filtered, the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (petroleum ether/ethyl acetate=1:1 to 1:2) to obtain the title compound (43.8 g, 65percent). [0585] 1H NMR (CDCl3, 400 MHz): δ 5.36-5.34 (m, 1H), 4.53-4.51 (m, 1H), 3.80 (s, 3H), 3.61-3.53 (m, 2H), 1.46 (s, 9H)
Reference: [1] Journal of Organic Chemistry, 2009, vol. 74, # 17, p. 6792 - 6796
[2] Organic Letters, 2003, vol. 5, # 24, p. 4599 - 4602
[3] Organic Letters, 2011, vol. 13, # 10, p. 2614 - 2617
[4] Tetrahedron, 2017, vol. 73, # 42, p. 6085 - 6091
[5] Tetrahedron Letters, 2007, vol. 48, # 16, p. 2857 - 2859
[6] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 12, p. 1199 - 1203
[7] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4427 - 4431
[8] Patent: WO2014/152127, 2014, A1, . Location in patent: Paragraph 00319; 00322
[9] Patent: WO2010/56877, 2010, A2, . Location in patent: Page/Page column 53
[10] Patent: US2015/51395, 2015, A1, . Location in patent: Paragraph 0584-0585
[11] Journal of the Chemical Society, Dalton Transactions, 2001, # 18, p. 2655 - 2662
[12] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 1, p. 191 - 195
[13] Phosphorus, Sulfur and Silicon and the Related Elements, 1998, vol. 136, p. 611 - 616
[14] Journal of the Chemical Society - Perkin Transactions 1, 1997, # 16, p. 2443 - 2447
[15] Synlett, 1997, vol. 1997, # 2, p. 169 - 170
[16] Tetrahedron Letters, 1994, vol. 35, # 4, p. 551 - 554
[17] Tetrahedron, 1985, vol. 41, # 10, p. 1833 - 1845
[18] Journal of the American Chemical Society, 2014, vol. 136, # 35, p. 12469 - 12478
[19] RSC Advances, 2015, vol. 5, # 64, p. 51807 - 51811
[20] Patent: US2016/185821, 2016, A1, . Location in patent: Paragraph 0383; 0384; 0385
[21] Arkivoc, 2016, vol. 2017, # 2, p. 260 - 271
[22] Organic Syntheses, 2005, vol. 81, p. 77 - 88
[23] Patent: WO2007/144379, 2007, A1, . Location in patent: Page/Page column 34
  • 39
  • [ 2766-43-0 ]
  • [ 55477-80-0 ]
  • [ 93267-04-0 ]
Reference: [1] Organic Syntheses, 2016, vol. 92, p. 103 - 116
[2] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 15, p. 4427 - 4431
  • 40
  • [ 2766-43-0 ]
  • [ 106930-51-2 ]
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 51, p. 9389 - 9392
  • 41
  • [ 2766-43-0 ]
  • [ 89985-86-4 ]
Reference: [1] Chemistry Letters, 1987, p. 2085 - 2088
  • 42
  • [ 2766-43-0 ]
  • [ 108149-63-9 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 4, p. 1218 - 1225
[2] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 2, p. 663 - 677
[3] Organic Letters, 2003, vol. 5, # 23, p. 4253 - 4256
[4] Tetrahedron, 1996, vol. 52, # 36, p. 11673 - 11694
[5] Journal of Organic Chemistry, 1987, vol. 52, # 12, p. 2361 - 2364
[6] Tetrahedron Letters, 1989, vol. 30, # 29, p. 3799 - 3802
[7] Medicinal Chemistry, 2014, vol. 10, # 6, p. 609 - 618
[8] Patent: KR2015/31544, 2015, A,
[9] Organic Syntheses, 2000, vol. 77, p. 64 - 64
[10] Angewandte Chemie - International Edition, 2018, vol. 57, # 18, p. 5147 - 5150[11] Angew. Chem., 2018, vol. 130, p. 5241 - 5244,4
[12] Organic Letters, 2018, vol. 20, # 12, p. 3574 - 3578
[13] Patent: WO2008/107365, 2008, A1,
[14] Patent: WO2005/41899, 2005, A2,
  • 43
  • [ 2766-43-0 ]
  • [ 125414-41-7 ]
Reference: [1] New Journal of Chemistry, 2018, vol. 42, # 4, p. 2450 - 2458
  • 44
  • [ 2766-43-0 ]
  • [ 57521-85-4 ]
Reference: [1] Tetrahedron Letters, 1987, vol. 28, # 48, p. 6069 - 6072
  • 45
  • [ 2766-43-0 ]
  • [ 104227-71-6 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 1, p. 19 - 22
  • 46
  • [ 2766-43-0 ]
  • [ 51293-47-1 ]
Reference: [1] Tetrahedron Letters, 1995, vol. 36, # 1, p. 67 - 70
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2766-43-0 ]

Amino Acid Derivatives

Chemical Structure| 1146954-88-2

[ 1146954-88-2 ]

(R)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-hydroxypropanoate

Similarity: 0.98

Chemical Structure| 7738-22-9

[ 7738-22-9 ]

Boc-Ser-OtBu

Similarity: 0.98

Chemical Structure| 86123-95-7

[ 86123-95-7 ]

(R)-2-((tert-Butoxycarbonyl)amino)-3-methoxypropanoic acid

Similarity: 0.98

Chemical Structure| 51293-47-1

[ 51293-47-1 ]

Boc-Ser(Me)-OH

Similarity: 0.98

Chemical Structure| 102831-44-7

[ 102831-44-7 ]

Diethyl 2-(tert-Butoxycarbonylamino)malonate

Similarity: 0.96